Recent Blog Articles

Cancer

New study once again casts doubt on PSA screening

iStock-479954170
April 06, 2018
  • By: Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Diseases

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Comments

Chuck Till
April 10, 2018

Age 51, asymptomatic with unremarkable DRE. First PSA of my life during a routine physical was 13. Doubled to 25 by the time I had surgery 3 months later. EPE noted during prostatectomy. All physicians on my case say it’s a virtual certainty I would have progressed to death within 10 years. With all respect, Dr Barry and the USPTF are full of it. Don’t tell me PSA screening doesn’t save lives. It saved mine.

KIN EGWUCHIM
April 08, 2018

We should also consider the negative predictive value of PSA screening.

Perhaps the millions of men who have a better quality of life because they are re-assured after a normal PSA test may outweigh the rare damage caused by the over-treatment of a few.

Have the researchers though of this?

Commenting has been closed for this post.